Results of Meeting
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Arovella Therapeutics Limited reports the results of its Annual General Meeting, where nine out of ten resolutions were approved by poll. The filing includes details of the proxies received and votes cast for each resolution, in compliance with ASX Listing rules and the Corporations Act.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Correction to previous CEO appointment announcement
- 2026 AGM Presentation
- Arovella Appoints CEO
- Complete tumour clearance in gastric cancer animal study
- First Patient Dosed with ALA-101
Later from Arovella Therapeutics
All Arovella Therapeutics news releasesFollow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics